Text Size

Impact of Treatment Induced Premature Menopause on Quality of Life

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00185718
First received: September 12, 2005
Last updated: December 12, 2012
Last verified: December 2012
History of Changes
  Purpose

To understand the impact of treatment induced menopause on quality of life and sexuality following blood and marrow transplantation.


Condition
Menopause, Premature

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Impact of Treatment Induced Premature Menopause on Quality of Life Following Blood and Marrow Transplantation

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Quality of life [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    To describe the impact of premature menopause on sexuality and quality of life.

  • Sexuality [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    To describe the impact of premature menopause on sexuality and quality of life.


Enrollment: 97
Study Start Date: November 2003
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Women become menopausal as a result of BMT

Criteria

Inclusion Criteria:

  • premenopausal
  • sexually active women
  • able to read and write English

Exclusion Criteria:

- postmenopausal females

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00185718

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Karl G. Blume Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00185718     History of Changes
Other Study ID Numbers: BMT160, 79700, BMT160, 13644
Study First Received: September 12, 2005
Last Updated: December 12, 2012
Health Authority: United States: Food and Drug Administration
United States: Institutional Review Board

Additional relevant MeSH terms:
Menopause, Premature
Primary Ovarian Insufficiency
Ovarian Diseases
Adnexal Diseases
 Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 23, 2013